WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity

Published:2023-03 Issue: Volume:556 Page:216058
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wei Xiaosong,Wang Beibei,Wu Zixin,Yang Xiaoming,Guo Yufeng,Yang Yang,Fang Zhiwei,Yi Chengzhi,Zhang Liuhui,Fan Xin,Zhang Lirong,Song Dongkui

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference47 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018

3. A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer;Selth;Oncogene,2017

4. CircCA12 promotes malignant process via sponging miR-1184 and upregulating RAS family in bladder cancer;Jiang;Front. Genet.,2021

5. WD40 repeat domain proteins: a novel target class?;Schapira;Nat. Rev. Drug Discov.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WDR77 in Pan-Cancer: Revealing expression patterns, genetic insights, and functional roles across diverse tumor types, with a spotlight on colorectal cancer;Translational Oncology;2024-11

2. SMEK1 promotes clear cell renal cell carcinoma progression via EGFR tyrosine-kinase dependent pathway;Cancer Letters;2024-10

3. Identification of Novel Therapeutic Targets for Head and Neck Squamous Cell Carcinoma Through Bioinformatics Analysis;2024-07-19

4. Copper in Cancer: from transition metal to potential target;Human Cell;2023-09-26

5. WDR54 exerts oncogenic roles in T‐cell acute lymphoblastic leukemia;Cancer Science;2023-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3